Alfresa Holdings (Alfresa Holdings) ROCE % : 10.83% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Alfresa Holdings ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Alfresa Holdings's annualized ROCE % for the quarter that ended in Dec. 2023 was 10.83%.

Alfresa Holdings ROCE % Historical Data

The historical data trend for Alfresa Holdings's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alfresa Holdings ROCE % Chart

Alfresa Holdings Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

ROCE %

Get a 7-Day Free Trial

12.09

6.96

8.92

7.16

7.87

Alfresa Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															12.50	4.87	8.59	10.83	9.55

Alfresa Holdings ROCE % Calculation

Alfresa Holdings's annualized ROCE % for the fiscal year that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2024 )		(A: Mar. 2023 )		(A: Mar. 2024 )
	=	293.201	/	( ( (10024.008 - 6177.656)	+	(9662.519 - 6053.915) )	/ 2 )
	=	293.201	/	( (3846.352	+	3608.604)	/ 2 )
	=	293.201	/	3727.478
	=	7.87 %

Alfresa Holdings's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	377.408	/	( ( (9646.698 - 6312.692)	+	(10418.797 - 6785.212) )	/ 2 )
	=	377.408	/	( ( 3334.006	+	3633.585 )	/ 2 )
	=	377.408	/	3483.7955
	=	10.83 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Alfresa Holdings (GREY:ALFRY) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Alfresa Holdings ROCE % Related Terms

Thank you for viewing the detailed overview of Alfresa Holdings's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Alfresa Holdings (Alfresa Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Alfresa Holdings Corp (GREY:ALFRY) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

2784:Japan

Address

1-1-3 Otemachi, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

http://www.alfresa.com

Alfresa Holdings Corp is a holding company engaged in the distribution of drugs. The company is in the Ethical Pharmaceuticals Wholesaling Business, the Self-Medication Products Wholesaling Business, the Manufacturing Business, and the Medical-Related Business. It mainly provides distributes diagnostic reagents and medical devices/equipment, health foods, supplements and other products to drug stores and pharmacies. The firm manufactures and markets high-quality active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices.

Alfresa Holdings (Alfresa Holdings) Headlines

No Headlines